您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Lu Tan1, Steffen Hirte2,3, Vincenzo Palmacci2,3
1Drug Discovery Sciences, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
由化合物特性引起的测试干扰在药物发现中带来了挑战. 本审查涵盖实验和in silico方法,以识别和减轻这些问题,以获得可靠的查结果.
10:28A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
Published on: August 17, 2019
14:43Microfluidic On-chip Capture-cycloaddition Reaction to Reversibly Immobilize Small Molecules or Multi-component Structures for Biosensor Applications
Published on: September 23, 2013
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: